Clinical Trials Directory

Trials / Completed

CompletedNCT05085730

Assessment Skin Quality and Efficacy of Dermal Line After Four Bipolar Radiofrequency Microneedling Treatments

Clinical Assessment of Skin Quality and Efficacy of Dermal Line Improvement Following Four Bipolar Radiofrequency Microneedling Treatments

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
13 (actual)
Sponsor
University of Texas Southwestern Medical Center · Academic / Other
Sex
All
Age
21 Years – 70 Years
Healthy volunteers
Accepted

Summary

This study intends to evaluate the safety and effectiveness of the InMode Morpheus8 System to treat facial and neck skin and assess its effect on skin quality and dermal lines. This device has been FDA cleared for full body subdermal adipose tissue remodeling.

Detailed description

The primary objective of this study is to evaluate the safety and efficacy of a bipolar fractional radiofrequency treatment via use of the InMode Morpheus8 System to achieve skin texture and quality change and to treat facial fine lines and wrinkles of the lower face.

Conditions

Interventions

TypeNameDescription
DEVICEInMode Morpheus8 SystemThe InMode Morpheus8 System is a bipolar fractional radiofrequency device which uses microneedles and thermal heat to stimulate neocollagenesis and neoelastogenesis.

Timeline

Start date
2022-01-14
Primary completion
2022-12-22
Completion
2022-12-22
First posted
2021-10-20
Last updated
2023-10-31
Results posted
2023-10-10

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05085730. Inclusion in this directory is not an endorsement.